- We will send in 10–14 business days.
/images/books/13225972/9783658167950.jpg)
- Author: Elisabeth Salzer
- Publisher: Springer
- ISBN-10: 3658167955
- ISBN-13: 9783658167950
- Format: 14.8 x 21 x 0.5 cm, softcover
- Language: English
- SAVE -10% with code: EXTRA
Identifying Novel Inborn Errors of the Immune System (e-book) (used book) | bookbook.eu
Reviews
Description
In her study Elisabeth Salzer describes three novel monogenic diseases. For CD27 deficiency Elisabeth Salzer describes a large cohort of patients. Although all patients shared the same causative missense mutation, they displayed diverse clinical presentations. In another patient she was able to identify a mutation in PRKCD resulting in a primary immunodeficiency with severe Lupus-like autoimmunity. The patient exhibited increased mRNA levels of IL6. Therefore, treatment with Tocilizumab, a humanized anti-IL-6 receptor monoclonal antibody was suggested. In a family with a history of deaths due to inflammatory bowel disease she identified a missense mutation in IL21. She produced wild type and mutated IL-21 protein and demonstrated a loss of function phenotype. As IL-21 is in clinical trials, she proposed a potentially curative treatment option. These discoveries contributed to the understanding of the multifaceted regulatory mechanisms of the immune system and highlighted essential players in these complex signaling networks.
EXTRA 10 % discount with code: EXTRA
The promotion ends in 20d.10:00:33
The discount code is valid when purchasing from 10 €. Discounts do not stack.
- Author: Elisabeth Salzer
- Publisher: Springer
- ISBN-10: 3658167955
- ISBN-13: 9783658167950
- Format: 14.8 x 21 x 0.5 cm, softcover
- Language: English English
In her study Elisabeth Salzer describes three novel monogenic diseases. For CD27 deficiency Elisabeth Salzer describes a large cohort of patients. Although all patients shared the same causative missense mutation, they displayed diverse clinical presentations. In another patient she was able to identify a mutation in PRKCD resulting in a primary immunodeficiency with severe Lupus-like autoimmunity. The patient exhibited increased mRNA levels of IL6. Therefore, treatment with Tocilizumab, a humanized anti-IL-6 receptor monoclonal antibody was suggested. In a family with a history of deaths due to inflammatory bowel disease she identified a missense mutation in IL21. She produced wild type and mutated IL-21 protein and demonstrated a loss of function phenotype. As IL-21 is in clinical trials, she proposed a potentially curative treatment option. These discoveries contributed to the understanding of the multifaceted regulatory mechanisms of the immune system and highlighted essential players in these complex signaling networks.
Reviews